ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627651 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627651; 2) Community: the network communities that were significantly associated with the response to NSC 627651; 3) Molecule: the relationships between components within communities and NSC 627651; 4) MDR: the compounds that were significantly associated with the NSC 627651.

NSC Compound Enrichment Correlation
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.00578566967432525 0.56302109
NSC 174121 Methotrexate Derivative 0.00578566967432527 -0.33774125
NSC 271674 Carboxyphthalatoplatinum 0.00578566967432527 -0.31379929
NSC 272346 1,7-Heptanediamine, N,N'-bis(2-methyl-7-nitro-4-quinolinyl)-, dihydrochloride 0.00578566967432527 -0.32443209
NSC 658368 Null 0.00645628049634952 -0.11827106
NSC 672219 Null 0.00645628049634952 -0.2558836
NSC 702734 Null 0.00645628049634952 -0.33660472
NSC 706995 Entinostat 0.00645628049634952 -0.24481321
NSC 710546 Null 0.00645628049634952 -0.17517076
NSC 737225 Null 0.00645628049634952 -0.17289508
Total:76  Current:13    [First] [Prev] [Next] [Last]